However, the mortality rates in the DXN and combination treatment (DXN + TIR) groups were 30% and 40%, respectively, on day 12, which was the end of the study (Figure 2)
Medical Writing Assistance The authors acknowledge the medical writing assistance of Caroline Freeman of Oxford PharmaGenesis, Oxford, UK (funded by Novo Nordisk A/S)
Presence of delta-sleep-inducing peptide-like material in human milk
Peptide tools can exhibit run to run drift when sourcing changes, when batch identity is unclear, or when storage and preparation assumptions vary between operators
We evaluate your BMI, medical history, and risk factors before prescribing